Tripartite Motif Containing 13 (TRIM13) Peptide
TRIM13
Reactivity: Human
Host: Synthetic
BP, WB
-
- Target See all TRIM13 products
- TRIM13 (Tripartite Motif Containing 13 (TRIM13))
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-RFP2 antibody (Catalog #: ARP34144_T100). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- TRIM13 (Tripartite Motif Containing 13 (TRIM13))
- Background
-
The protein encoded by RFP2 is a member of the tripartite motif (TRIM) family. The TRIM motif includes three zinc-binding domains, a RING, a B-box type 1 and a B-box type 2, and a coiled-coil region. The protein localizes to cytoplasmic bodies near the nucleus, but its function is unknown. RFP2 is located on chromosome 13 within the minimal deletion region for B-cell chronic lymphocytic leukemia.
Alias Symbols: CAR, LEU5, RFP2, DLEU5, RNF77
Protein Size: 407 - Molecular Weight
- 45 kDa
- Gene ID
- 10206
- NCBI Accession
- NM_052811, NP_434698
- UniProt
- O60858
-
You are here:
